🏥Public HealthFDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee
The White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
🏥Public HealthThe White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
🏥Public HealthFollowing earlier pauses and funding cuts, the U.S. State Department has introduced the America First Global Health Strategy, tying foreign aid more directly to U.S. nati…
🏥Public HealthNumerous states are utilizing federal funding to attract medical professionals to underserved rural areas through service-commitment programs, though questions persist re…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.